Followi g a i itial deployme t at o e Fi st Fe tility ce te , st o g patie t feedback a d positive adoptio i to the cli ical a d labo ato y wo kflow led the etwo k to expa d CHLOE ac oss its existi g timelapse labo ato ies a d i t oduce the platfo m at additio al ce te s as they adopt timelapse tech ology.
IVF patie ts i c easi gly expect g eate t a spa e cy, educatio , a d co ectio th oughout t eatme t, pa ticula ly du i g emb yo developme t, whe commu icatio ca be limited a d a xiety is ofte highest. Fi st Fe tility’s expa ded deployme t eflects a b oade shift towa d tech ologies that ot o ly e ha ce cli ical wo kflow but also help patie ts bette u de sta d a d e gage with thei ca e.As o e of the atio ‘s leadi g fe tility etwo ks, Fi st Fe tility is committed to thoughtfully evaluati g a d impleme ti g i ovatio s that elevate both cli ical excelle ce a d the patie t expe ie ce ac oss its g owi g etwo k of fe tility ce te s. The expa sio of CHLOE eflects that commitme t, p ovidi g physicia s, emb yologists, a d patie ts with tech ology that foste s g eate t a spa e cy, e gageme t, a d co fide ce th oughout the IVF jou ey.
CHLOE leve ages time-lapse imagi g to p ovide cli ics with u ique patie t e gageme t capabilities that c eate a mo e pe so alized a d t a spa e t IVF expe ie ce, while suppo ti g co fide t cli ical decisio -maki g.
“We i itially i t oduced CHLOE at o e ce te to u de sta d how it could e ha ce ou
labo ato y wo kffow a d imp ove the patie t expe ie ce,” said D . Aliso Ba tolucci, Chief Scie tific Office of Fi st Fe tility. “The espo se f om patie ts was ext emely positive. They app eciated havi g g eate visibility i to emb yo developme t a d felt mo e co ected to thei t eatme t. Based o that expe ie ce, expa di g CHLOE ac oss ou existi g time-lapse labo ato ies—a d i t oduci g it as additio al ce te s adopt time-lapse—was a atu al ext step.”
“The futu e of IVF is ot o ly about imp ovi g emb yo assessme t – it is also about givi g patie ts g eate t a spa e cy a d helpi g them feel mo e i fo med th oughout t eatme t,” said E a Eshed, CEO a d Co-Fou de of Fai tility. “Fi st Fe tility ecog ized ea ly that such tech ologies ca c eate value fo both the labo ato y a d the patie t. The decisio to expa d CHLOE followi g its i itial deployme t effects the st e gth of that sha ed visio .”
The Fi st Fe tility deployme t is the latest additio to Fai tility’s apidly g owi g CHLOE cli ic base, which ow i cludes mo e tha 100 fe tility cli ics ac oss No th Ame ica, Eu ope, Asia-Pacific, a d Lati Ame ica.
Fai tility is the global leade i AI-powe ed IVF i tellige ce softwa e. Its flagship softwa e, CHLOE™, combi es t a spa e t AI, emb yo a d egg quality assessme t, wo kflow optimizatio , ope atio al i tellige ce, a d patie t e gageme t i a si gle softwa e solutio built o time-lapse imagi g. Used by mo e tha 100 fe tility cli ics wo ldwide, CHLOE empowe s emb yologists a d cli icia s with explai able AI while helpi g cli ics imp ove efficie cy, e ha ce patie t commu icatio , a d delive a mo e pe so alized IVF expe ie ce. Fo mo e i fo matio , visit www.fai tility.com
Fi st Fe tility is a etwo k of fe tility ce te s ac oss the U ited States, with locatio s i Alabama, Califo ia, Co ecticut, Flo ida, Illi ois, Louisia a, Mai e, Massachusetts,Missou i, New Hampshi e, New Yo k, Oklahoma, Rhode Isla d, a d Texas. Each ce te
offe s customized a d compassio ate fe tility ca e to help patie ts g ow thei families. We ot o ly i vest i ep oductive e doc i ology p actices atio wide, but we also build st ategic pa t e ships that put the focus o what matte s most: taki g ca e of patie ts.
Lea mo e at fi stfe tility.com.
Fai tility
2 HaShlosha St, 6706062
Is ael
Compa y Numbe : 516122454
VAT Numbe : 516122454
Withheld Tax File: 936425032
Fai tility: i fo@fai tility.com
Website: https://www.fai tility.com/
Fi st Fe tility: Je Be esch, ma keti g@fi stfe tility.com
